Downregulation of MicroRNA-495 Alleviates IL-1β Responses among Chondrocytes by Preventing SOX9 Reduction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Our previous work demonstrated that miRNA-495 targets SOX9 to inhibit chondrogenesis of mesenchymal stem cells. In this study, we aimed to investigate whether miRNA-495-mediated SOX9 regulation could be a novel therapeutic target for osteoarthritis(OA) using an in vitro cell culture model. Materials and Methods: An in vitro model mimicking the OA environment was established using TC28a2 normal human chondrocytecells. Interleukin-1β (IL-1β, 10 ng/mL) was utilized to induce inflammation-related changes in TC28a2 cells. Safranin Ostaining and glycosaminoglycan assay were used to detect changes in proteoglycans among TC28a2 cells. Expression levels ofCOX-2, ADAMTS5, MMP13, SOX9, CCL4, and COL2A1 were examined by qRT-PCR and/or Western blotting. Immunohistochemistrywas performed to detect SOX9 and CCL4 proteins in human cartilage tissues obtained from patients with OA. Results: miRNA-495 was upregulated in IL-1β-treated TC28a2 cells and chondrocytes from damaged cartilage tissues of patientswith OA. Anti-miR-495 abolished the effect of IL-1β in TC28a2 cells and rescued the protein levels of SOX9 and COL2A1, whichwere reduced by IL-1β. SOX9 was downregulated in the damaged cartilage tissues of patients with OA, and knockdown of SOX9abolished the effect of anti-miR-495 on IL-1β-treated TC28a2 cells. Conclusion: We demonstrated that inhibition of miRNA-495 alleviates IL-1β-induced inflammatory responses in chondrocytesby rescuing SOX9 expression. Accordingly, miRNA-495 could be a potential novel target for OA therapy, and the application ofanti-miR-495 to chondrocytes could be a therapeutic strategy for treating OA.
Abstract
Purpose: Our previous work demonstrated that miRNA-495 targets SOX9 to inhibit chondrogenesis of mesenchymal stem cells. In this study, we aimed to investigate whether miRNA-495-mediated SOX9 regulation could be a novel therapeutic target for osteoarthritis(OA) using an in vitro cell culture model. Materials and Methods: An in vitro model mimicking the OA environment was established using TC28a2 normal human chondrocytecells. Interleukin-1β (IL-1β, 10 ng/mL) was utilized to induce inflammation-related changes in TC28a2 cells. Safranin Ostaining and glycosaminoglycan assay were used to detect changes in proteoglycans among TC28a2 cells. Expression levels ofCOX-2, ADAMTS5, MMP13, SOX9, CCL4, and COL2A1 were examined by qRT-PCR and/or Western blotting. Immunohistochemistrywas performed to detect SOX9 and CCL4 proteins in human cartilage tissues obtained from patients with OA. Results: miRNA-495 was upregulated in IL-1β-treated TC28a2 cells and chondrocytes from damaged cartilage tissues of patientswith OA. Anti-miR-495 abolished the effect of IL-1β in TC28a2 cells and rescued the protein levels of SOX9 and COL2A1, whichwere reduced by IL-1β. SOX9 was downregulated in the damaged cartilage tissues of patients with OA, and knockdown of SOX9abolished the effect of anti-miR-495 on IL-1β-treated TC28a2 cells. Conclusion: We demonstrated that inhibition of miRNA-495 alleviates IL-1β-induced inflammatory responses in chondrocytesby rescuing SOX9 expression. Accordingly, miRNA-495 could be a potential novel target for OA therapy, and the application ofanti-miR-495 to chondrocytes could be a therapeutic strategy for treating OA.
참고문헌 (44)
- Zhang Y, "Epidemiology of osteoarthritis", Clin Geriatr Med, 26, pp.355~369 (2010)
- Akkiraju H, "Role of chondrocytes in cartilage formation, progression of osteoarthritis and cartilage regeneration", J Dev Biol, 3, pp.177~192 (2015)
- Archer CW, "The chondrocyte", Int J Biochem Cell Biol, 35, pp.401~404 (2003)
- Kim JH, "Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis", Cell, 156, pp.730~743 (2014)
- Mobasheri A, "The role of metabolism in the pathogenesis of osteoarthritis", Nat Rev Rheumatol, 13, pp.302~311 (2017)
- Hoshi H, "Effect of inhibiting MMP13 and ADAMTS5 by intraarticular injection of small interfering RNA in a surgically induced osteoarthritis model of mice", Cell Tissue Res, 368, pp.379~387 (2017)
- Miyauchi A, "Alleviation of murine osteoarthritis by deletion of the focal adhesion mechanosensitive adapter, Hic-5", Sci Rep, 9, pp.15770~ (2019)
- van der Kraan PM, "Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?", Osteoarthritis Cartilage, 20, pp.223~232 (2012)
- Yu C, "MicroRNA in osteoarthritis", J Int Med Res, 39, pp.1~9 (2011)
- Alvarez-Garcia I, "MicroRNA functions in animal development and human disease", Development, 132, pp.4653~4662 (2005)
- Miyaki S, "Macro view of microRNA function in osteoarthritis", Nat Rev Rheumatol, 8, pp.543~552 (2012)
- Lee S, "microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9", Stem Cells Dev, 23, pp.1798~1808 (2014)
- Zhao X, "MicroRNA-495 enhances chondrocyte apoptosis, senescence and promotes the progression of osteoarthritis by targeting AKT1", Am J Transl Res, 11, pp.2232~2244 (2019)
- Yang DW, "Inhibition of microRNA-495 suppresses chondrocyte apoptosis through activation of the NF-κB signaling pathway by regulating CCL4 in osteoarthritis", Gene Ther, 26, pp.217~229 (2019)
- Yoon DS, "The effects of COX-2 inhibitor during osteogenic differentiation of bone marrow derived human mesenchymal stem cells", Stem Cells Dev, 19, pp.1523~1533 (2010)
- Yoon DS, "Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture", Cell Prolif, 44, pp.428~440 (2011)
- Mitchell PG, "Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage", J Clin Invest, 97, pp.761~768 (1996)
- Echtermeyer F, "Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis", Nat Med, 15, pp.1072~1076 (2009)
- Wang M, "Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis", Ann N Y Acad Sci, 1240, pp.61~69 (2011)
- Chen H, "Expression, regulation and function of miR-495 in healthy and tumor tissues", Oncol Lett, 13, pp.2021~2026 (2017)
- Zhang Z, "CCAAT", enhancer-binding protein β and NF-κB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1β, 2010, pp.285, 33092~33103
- Malemud CJ, "MicroRNAs and osteoarthritis", Cells, 7, pp.92~ (2018)
- Sondag GR, "The role of microRNAs and their targets in osteoarthritis", Curr Rheumatol Rep, 18, pp.56~ (2016)
- Leung VY, "SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression", PLoS Genet, 7, pp.e1002356~ (2011)
- Cao L, "The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells", Biomaterials, 32, pp.3910~3920 (2011)
- Fellows CR, "Characterisation of a divergent progenitor cell sub-populations in human osteoarthritic cartilage : the role of telomere erosion and replicative senescence", Sci Rep, 7, pp.41421~ (2017)
- Campbell TM, "Mesenchymal stem cell alterations in bone marrow lesions in patients with hip osteoarthritis", Arthritis Rheumatol, 68, pp.1648~1659 (2016)
- Cucchiarini M, "Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9", Arthritis Rheum, 56, pp.158~167 (2007)
- Li Y, "Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9", Tissue Eng, 10, pp.575~584 (2004)
- Tew SR, "Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes", Osteoarthritis Cartilage, 13, pp.80~89 (2005)
- Ouyang Y, "Overexpression of SOX9 alleviates the progression of human osteoarthritis in vitro and in vivo", Drug Des Devel Ther, 13, pp.2833~2842 (2019)
- Lu H, "Lentiviral vectormediated over-expression of Sox9 protected chondrocytes from IL-1β induced degeneration and apoptosis", Int J Clin Exp Pathol, 8, pp.10038~10049 (2015)
- Tian Z, "MicroRNA-495 inhibits new bone regeneration via targeting high mobility group AT-Hook 2(HMGA2)", Med Sci Monit, 23, pp.4689~4698 (2017)
- Zhu L, "MicroRNA-495downregulates AQP1 and facilitates proliferation and differentiation of osteoblasts in mice with tibial fracture through activation of p38 MAPK signaling pathway", Sci Rep, 9, pp.16171~ (2019)
- Liang J, "Inhibition of microRNA-495 enhances therapeutic angiogenesis of human induced pluripotent stem cells", Stem Cells, 35, pp.337~350 (2017)
- Zhang B, "Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of MYB", Mol Med Rep, 14, pp.977~982 (2016)
- Yang H, "MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma", J Clin Invest, 123, pp.285~298 (2013)
- Hwang-Verslues WW, "miR-495 is upregulated by E12", E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1, 2011, pp.30, 2463~2474
- Chen SM, "MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6", World J Surg Oncol, 11, pp.87~ (2013)
- Jiang X, "MiR-495 is a tumorsuppressor microRNA down-regulated in MLL-rearranged leukemia", Proc Natl Acad Sci U S A, 109, pp.19397~19402 (2012)
- Yan S, "MicroRNA34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1", p53 signaling pathway during the pathogenesis of osteoarthritis, 2016, pp.38, 201~209
- Zhang X, "miR-146a facilitates osteoarthritis by regulating cartilage homeostasis via targeting Camk2d and Ppp3r2", Cell Death Dis, 8, pp.e2734~ (2017)
- Wang H, "Intra-articular delivery of antago-miR-483-5p inhibits osteoarthritis by modulating matrilin 3 and tissue inhibitor of metalloproteinase 2", Mol Ther, 25, pp.715~727 (2017)
- Milone MC, "Clinical use of lentiviral vectors", Leukemia, 32, pp.1529~1541 (2018)
